


Ask a doctor about a prescription for ATOZET 10 mg/40 mg FILM-COATED TABLETS
Package Leaflet: Information for the User
ATOZET 10mg/20mg film-coated tablets
ATOZET 10mg/40mg film-coated tablets
ATOZET 10mg/80mg film-coated tablets
ezetimibe/atorvastatin
(ezetimibe/atorvastatin)
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
ATOZET is a medicine that lowers high cholesterol levels. ATOZET contains ezetimibe and atorvastatin.
ATOZET is used in adults to lower the levels of total cholesterol, “bad” cholesterol (LDL cholesterol) and substances called triglycerides that circulate in the blood. In addition, ATOZET raises the levels of “good” cholesterol (HDL cholesterol).
ATOZET works by reducing cholesterol in two ways. It reduces the cholesterol absorbed in the digestive tract, as well as the cholesterol produced by your body.
Cholesterol is one of the fatty substances that are found in the bloodstream. Your total cholesterol is mainly made up of LDL and HDL cholesterol.
LDL cholesterol is often called “bad” cholesterol because it can build up in the walls of your arteries, forming plaques. Over time, this buildup of plaque can cause the arteries to narrow, which can slow down or block the blood flow to vital organs such as the heart and brain. This interruption of blood flow can trigger a heart attack or stroke.
HDL cholesterol is often called “good” cholesterol because it helps prevent the bad cholesterol from building up in the arteries and protects them from heart disease.
Triglycerides are another type of fat found in your blood that can increase the risk of heart disease.
ATOZET is used in patients who cannot control their cholesterol levels by diet alone. While taking this medicine, you should follow a cholesterol-lowering diet.
ATOZET is used, along with a cholesterol-lowering diet, if you have:
ATOZET does not help you lose weight.
Do not take ATOZET
Warnings and precautions
Consult your doctor or pharmacist before starting to take ATOZET
Contact your doctor as soon as possible if you experience unexplained muscle pain, tenderness, or muscle weakness while taking ATOZET.This is because muscle problems can be serious, including muscle breakdown that can cause kidney damage. Atorvastatin can cause muscle problems, and muscle problems have also been reported with ezetimibe.
Also, inform your doctor or pharmacist if you experience persistent muscle weakness. You may need additional tests and medicines to diagnose and treat this problem.
Consult your doctor or pharmacist before starting to take ATOZET:
If you are in any of the above situations (or are unsure), consult your doctor before starting to take ATOZET, as your doctor will need to perform a blood test before starting your treatment with ATOZET, and possibly during treatment, to predict the risk you have of experiencing muscle side effects. It is known that the risk of muscle side effects, e.g., rhabdomyolysis, increases when certain medicines are taken at the same time (see section 2 “Taking ATOZET with other medicines”).
While you are taking this medicine, your doctor will check if you have diabetes or are at risk of developing diabetes. This risk of diabetes increases if you have high levels of sugar and fat in the blood, are overweight, and have high blood pressure.
Tell your doctor about all your medical problems, including allergies.
The combined use of ATOZET and fibrates (certain medicines to lower cholesterol) should be avoided, as the combined use of ATOZET and fibrates has not been studied.
Children
ATOZET is not recommended for children and adolescents.
Taking ATOZET with other medicines
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines, including those obtained without a prescription.
There are some medicines that can affect the way ATOZET works or that can increase the risk of side effects (see section 3). This type of interaction could decrease the effectiveness of one or both medicines. On the other hand, it could also increase the risk or severity of side effects, including a serious disorder in which muscle is destroyed, known as “rhabdomyolysis”, which is described in section 4:
** If you have to take fusidic acid orally to treat a bacterial infection, you will have to stop using this medicine temporarily. Your doctor will tell you when you can restart treatment with ATOZET. The use of ATOZET with fusidic acid can rarely cause muscle weakness, tenderness, or pain (rhabdomyolysis). For more information on rhabdomyolysis, see section 4
Taking ATOZET with food and drink
See section 3 for instructions on how to take ATOZET. Please note the following:
Grapefruit juice
Do not drink more than one or two small glasses of grapefruit juice per day, as large amounts of grapefruit juice can affect the way ATOZET works.
Alcohol
Avoid excessive alcohol consumption while taking this medicine. For more details, see section 2 “Warnings and precautions”.
Pregnancy and breastfeeding
Do not take ATOZET if you are pregnant, trying to become pregnant, or think you may be pregnant. Do not take ATOZET if you can become pregnant, unless you use reliable contraceptive methods. If you become pregnant while taking ATOZET, stop taking it immediately and inform your doctor.
Do not take ATOZET if you are breastfeeding.
The safety of ATOZET during pregnancy and breastfeeding has not yet been established.
Consult your doctor or pharmacist before taking this medicine.
Driving and using machines
ATOZET is not expected to affect your ability to drive or use machines. However, it should be taken into account that some people experience dizziness after taking ATOZET.
ATOZET contains lactose
ATOZET tablets contain a sugar called lactose. If your doctor has told you that you have an intolerance to some sugars, contact them before taking this medicine.
ATOZET contains sodium
This medicine contains less than 23 mg of sodium (1 mmol) per tablet; this is essentially “sodium-free”.
Follow exactly the administration instructions of this medicine given by your doctor. Your doctor will determine the appropriate dose per tablet for you, depending on your current treatment and your personal risk situation. In case of doubt, consult your doctor or pharmacist again.
How much to take
The recommended dose is one ATOZET tablet once a day by mouth.
Method of administration
Take ATOZET at any time of the day. You can take it with or without food.
If your doctor has prescribed ATOZET along with colestyramine or any other bile acid sequestrant (medicines that lower cholesterol levels), you should take ATOZET at least 2 hours before or 4 hours after taking the bile acid sequestrant.
If you take more ATOZET than you should
Consult your doctor or pharmacist.
If you forget to take ATOZET
Do not take an extra dose; the next day, take your normal amount of ATOZET at the usual time.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
If you experience any of the following serious adverse effects or symptoms, stop taking your tablets and immediately inform your doctor, or go to the emergency department of the nearest hospital.
Consult your doctor as soon as possible if you experience problems associated with the unexpected or unusual appearance of bleeding or bruising, as this fact may be indicative of a liver condition.
The following frequent adverse effects have been reported (may affect up to 1 in 10 patients):
The following infrequent adverse effects have been reported (may affect up to 1 in 100 patients):
The following adverse effects have been reported with an unknown frequency (the frequency cannot be estimated from the available data):
Consult your doctor if you experience weakness in the arms or legs that worsens after periods of activity, double vision, or drooping eyelids, difficulty swallowing, or difficulty breathing.
Additionally, the following adverse effects have been reported in people taking ATOZET, ezetimibe, or atorvastatin tablets:
Possible adverse effects reported with some statins
Reporting of Adverse Effects
If you experience any type of adverse effect, consult your doctor, pharmacist, or nurse, even if it is a possible adverse effect that does not appear in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Medicines should not be thrown away through wastewater or household waste. Deposit the packaging and medicines you no longer need at the SIGRE point in the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This way, you will help protect the environment.
Composition of ATOZET
The active ingredients are ezetimibe and atorvastatin. Each film-coated tablet contains 10 mg of ezetimibe and 20 mg, 40 mg, or 80 mg of atorvastatin (as atorvastatin calcium trihydrate).
The other ingredients are: calcium carbonate; anhydrous colloidal silica; sodium croscarmellose; hydroxypropylcellulose; lactose monohydrate; magnesium stearate; microcrystalline cellulose; polysorbate 80; povidone; sodium lauryl sulfate.
The tablet coating contains: hypromellose, macrogol 8000, titanium dioxide (E-171), and talc.
Appearance of the Product and Package Contents
Film-coated tablets, capsule-shaped, biconvex, and white to bone-colored.
ATOZET10 mg/20 mg tablets: with the code "333" on one side
ATOZET10 mg/40 mg tablets: with the code "337" on one side
ATOZET10 mg/80 mg tablets: with the code "357" on one side
Package sizes:
Packaging of 10, 30, 90, and 100 film-coated tablets in aluminum/aluminum blisters (oriented polyamide-aluminum-PVC with an aluminum cover).
Packaging of 30 x 1 and 45 x 1 film-coated tablets in unit doses, aluminum/aluminum blisters (oriented polyamide-aluminum-PVC with an aluminum cover).
Only some package sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder:
Organon Salud, S.L.
Paseo de la Castellana, 77
28046 Madrid
Spain
Tel.: 915911279
Manufacturer:
Merck Sharp & Dohme B.V.
Waarderweg 39
2031 BN Haarlem
Netherlands
Organon Heist bv
Industriepark 30
2220 Heist-op-den-Berg
Belgium
Organon N.V.
Kloosterstraat 6, 5349 AB,
Oss, Netherlands.
This medicine is authorized in the Member States of the European Economic Area under the following names:
ATOZET: Austria, Belgium, Bulgaria, Croatia, Denmark, Germany, Iceland, Ireland, Italy, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, and Sweden
LIPTRUZET: Cyprus, France, Greece, and Hungary
ZOLETORV: Czech Republic
Date of the Last Revision of this Leaflet:07/2023.
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es
The average price of ATOZET 10 mg/40 mg FILM-COATED TABLETS in November, 2025 is around 27.52 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for ATOZET 10 mg/40 mg FILM-COATED TABLETS – subject to medical assessment and local rules.